Erlotinib: The Targeted Therapy for Lung Cancer
What is Erlotinib?
Erlotinib is a targeted therapy used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It blocks the EGFR (epidermal growth factor receptor), which is essential for cancer cell growth.
How Erlotinib Works
Erlotinib inhibits EGFR, preventing cancer cells from dividing and growing, effectively slowing tumor progression.
When to Use Erlotinib
● Lung Cancer: Primarily used for advanced non-small cell lung cancer.
● Pancreatic Cancer: Used for advanced cases.
Dosage in adults : For non-small cell lung cancer (NSCLC) it is used as 150 mg once a day it may be used along with other monoclonal antibiotics (as per the oncologist’s decision). For Pancreatic cancer it is given 100 mg orally along with Gemcitabine.
Side Effects
● Diarrhea, skin rash, liver toxicity, fatigue.
Common Brands in India: Zyceva, Tarceva.
FAQ
Does Erlotinib cause hair loss?
Mild hair thinning may occur, but it does not typically cause complete hair loss.
Disclaimer
Always consult your oncologist for proper dosing. HealthPil connects you with oncology experts for targeted cancer therapies.